Do lupus disease activity measures detect clinically important change?

Journal of Rheumatology

Volumn 27, Issue 6, 2000, Pages 1421-1428

  Fortin, Paul R ^a,b,e   Abrahamowicz, Michal ^a,b   Clarke, Ann E ^a,b   Neville, Carolyn ^a,b   Du Berger, Roxane ^a,b   Fraenkel, Liana ^c   Liang, Matthew H ^d  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Division of Rheumatology   (United States)

^e TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Disease activity; Effect size; Responsiveness; Sensitivity; SLE activity; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RATING SCALE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACTIVITIES OF DAILY LIVING; ADULT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0034123579     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lockshin MD. Therapy for systemic lupus erythematosus. N Engl J Med 1991;324:189-91.
2. Liang M, Stern S, Esdaile J. Systemic lupus erythematosus activity. Rheum Dis Clin North Am 1988;14:57-66.
3. Liang M, Socher S, Roberts W, Esdaile J. Current comment: measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988;31:817-25.
4. Liang M, Socher S, Larson M, Schur P. Reliability and validity of six systems for the clinical assessment of disease activity in SLE. Arthritis Rheum 1989;31:1107-18.
5. Bombardier C, Gladman D, Urowitz M, Caron D, Chang C, The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
6. Hay E, Bacon P, Gordon C, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993;86:447-58.
7. Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 1992;19:53-9.
8. Benivelli W, Vitali C, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research III. Development of a computerized clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:549-54.
9. Fortin PR, Abrahamowicz M, Danoff D. Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory tests. J Rheumatol 1995;22:2078-83.
10. Fortin PR, Stucki G, Katz JN. Measuring relevant change: an emerging challenge in rheumatologic clinical trials [editorial]. Arthritis Rheum 1995;38:1027-30.
11. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991;34:937-44.
12. Gladman DD, Goldsmith CH, Urowitz MB, et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994;21:1468-71.
13. Katz J, Larson M, Phillips C, Fossel A, Liang M. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917-25.
14. Kazis L, Anderson J, Meenan R. Effect sizes for interpreting changes in health status. Med Care 1989;27:5178-89.
15. Deyo R, Diehr P, Patrick D. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clin Trials 1991;12:1425-585.
16. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171-8.
17. Tan E, Cohen A, Fries J, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Abrahamowicz M, Fortin PR, du Berger R, Nayak V, Neville C, Liang MH. The relationship between disease activity and physician's decision to start treatment in active systemic lupus erythematosus. J Rheumatol 1998;25:277-84.
19. Hanley JA. Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imag 1989;29:307-35.
20. Abrahamowicz M, Ramsay J. Multicategorical spline model for item response theory. Psychometrika 1992;57:5-27.
21. Fortin PR, Abrahamowicz M, Neville C, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998;7:101-7.
22. Cohen J. The t test for means. In: Erlbaum L, editor. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum Associates; 1998:19-74.
23. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 1996;39:363-9.